Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
SpringWorks Therapeutics (SWTX) had Receiveable Turnover of 0.92 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$5.45M |
|
$-325.10M |
|
$0.42M |
|
$5.03M |
|
$348.46M |
|
$-343.01M |
|
$17.91M |
|
$-325.10M |
|
$-325.10M |
|
$-325.10M |
|
$-325.10M |
|
$-325.10M |
|
$-325.10M |
|
$-343.01M |
|
$-341.35M |
|
63.12M |
|
63.12M |
|
$-5.15 |
|
$-5.15 |
|
| Balance Sheet Financials | |
$500.91M |
|
$17.94M |
|
$224.88M |
|
$725.79M |
|
$78.17M |
|
-- |
|
$21.40M |
|
$99.57M |
|
$626.22M |
|
$626.22M |
|
$626.22M |
|
73.49M |
|
| Cash Flow Statement Financials | |
$-222.79M |
|
$34.75M |
|
$296.64M |
|
$68.07M |
|
$176.67M |
|
$108.60M |
|
$94.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.41 |
|
-- |
|
-- |
|
-- |
|
-- |
|
92.25% |
|
-6297.28% |
|
-6297.28% |
|
-6266.68% |
|
-5968.50% |
|
-5968.50% |
|
$-230.18M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.14 |
|
|
Receiveable Turnover |
0.92 |
397.37 |
|
-51.92% |
|
-51.92% |
|
-44.79% |
|
-51.92% |
|
$8.52 |
|
$-3.65 |
|
$-3.53 |
|